Unknown

Dataset Information

0

Bell's palsy following the Ad26.COV2.S COVID-19 vaccination.

ABSTRACT:

SUBMITTER: Nishizawa Y 

PROVIDER: S-EPMC8244554 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
| S-EPMC8282116 | biostudies-literature
Unknown Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination.
| S-EPMC8421108 | biostudies-literature
Unknown Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.
| S-EPMC8550921 | biostudies-literature
Unknown Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.
| S-EPMC8550908 | biostudies-literature
Unknown Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination.
| S-EPMC8635656 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
| S-EPMC8063883 | biostudies-literature
Unknown Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
| S-EPMC7953339 | biostudies-literature
Unknown Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study.
| S-EPMC8566165 | biostudies-literature
Unknown Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
| S-EPMC8220996 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.
| S-EPMC8117965 | biostudies-literature